{"version":"1.0","provider_name":"INCYTE","provider_url":"https:\/\/incyteonco.ca\/fr\/","title":"ZYNYZ HCP - INCYTE","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"2cwQ5APpRE\"><a href=\"https:\/\/incyteonco.ca\/fr\/zynyz-hcp\/\">ZYNYZ HCP<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/incyteonco.ca\/fr\/zynyz-hcp\/embed\/#?secret=2cwQ5APpRE\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0ZYNYZ HCP\u00a0\u00bb &#8212; INCYTE\" data-secret=\"2cwQ5APpRE\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/incyteonco.ca\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Les outils les plus r\u00e9cents sur PrZYNYZ\u00ae regroup\u00e9s au m\u00eame endroit ZYNYZ\u00ae (r\u00e9tifanlimab pour injection), en monoth\u00e9rapie, est indiqu\u00e9 pour le traitement de premi\u00e8re intention des patients adultes atteints d\u2019un carcinome \u00e0 cellules de Merkel (CCM) m\u00e9tastatique ou r\u00e9cidivant localement avanc\u00e9 ne relevant pas de la chirurgie curative ou de la radioth\u00e9rapie1. Les ressources ci-dessous [&hellip;]","thumbnail_url":"https:\/\/incyteonco.ca\/wp-content\/uploads\/2025\/09\/ZYNYZ-Logo-Canada-FR.png","thumbnail_width":1525,"thumbnail_height":994}